67 related articles for article (PubMed ID: 2000173)
1. [Increase of beta 2-microglobulin in drug addicts with anti-HIV antibodies and high risk of AIDS].
D'Angelo G; Giardini C; Zanco MD; Calvano D; Crovetti G; De Filippo C
Minerva Med; 1991; 82(1-2):45-8. PubMed ID: 2000173
[TBL] [Abstract][Full Text] [Related]
2. Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection.
Franzetti F; Cavalli G; Foppa CU; Amprimo MC; Gaido P; Lazzarin A
J Clin Lab Immunol; 1988 Nov; 27(3):133-7. PubMed ID: 3073225
[TBL] [Abstract][Full Text] [Related]
3. [The serum beta-2-microglobulin values in drug addicts with persistent generalized lymphadenopathy].
De Mercato R; Perna E; Oriani G; Siciliano V; Iovinella V; Ciampi R; Bassi A; Tagliaferro R
Minerva Med; 1990 Apr; 81(4):271-3. PubMed ID: 2188168
[TBL] [Abstract][Full Text] [Related]
4. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
Halota W; Jaruga B; Pawłowska M
Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
[TBL] [Abstract][Full Text] [Related]
5. Serum beta 2-microglobulin and human immunodeficiency virus infection.
Lacey JN; Forbes MA; Waugh MA; Cooper EH; Hambling MH
AIDS; 1987 Jul; 1(2):123-7. PubMed ID: 3130078
[TBL] [Abstract][Full Text] [Related]
6. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
7. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
8. Abnormal urinary protein excretion in HIV-infected patients.
Kimmel PL; Umana WO; Bosch JP
Clin Nephrol; 1993 Jan; 39(1):17-21. PubMed ID: 8428402
[TBL] [Abstract][Full Text] [Related]
9. Distribution of antibodies against denatured collagen in AIDS risk groups and homosexual AIDS patients suggests a link between autoimmunity and the immunopathogenesis of AIDS.
Grant MD; Weaver MS; Tsoukas C; Hoffmann GW
J Immunol; 1990 Feb; 144(4):1241-50. PubMed ID: 2406340
[TBL] [Abstract][Full Text] [Related]
10. [A high fraction of drug-dependent patients among anonymously detected HIV-infected patients in Stuttgart].
Marquart KH
Offentl Gesundheitswes; 1989 Mar; 51(3):115-7. PubMed ID: 2524695
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
[No Abstract] [Full Text] [Related]
12. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic laboratory tests in acquired immunodeficiency syndrome (AIDS) and suspected AIDS].
Joller-Jemelka HI; Vogt M; Joller PW
Schweiz Med Wochenschr; 1985 Jan; 115(4):125-32. PubMed ID: 3156402
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
15. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
[TBL] [Abstract][Full Text] [Related]
16. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
17. A clinical-immunological evaluation of AIDS cases and related syndromes.
Gritti FM; Raise E; Gualandi G; Bonazzi L; Martuzzi M; Schiattone ML; Di Pede B; Gallo R; Rivano MT; Taruscio D
J Exp Pathol; 1987; 3(4):723-36. PubMed ID: 3483882
[TBL] [Abstract][Full Text] [Related]
18. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.
Des Jarlais DC; Friedman SR; Marmor M; Cohen H; Mildvan D; Yancovitz S; Mathur U; el-Sadr W; Spira TJ; Garber J
AIDS; 1987 Jul; 1(2):105-11. PubMed ID: 2896511
[TBL] [Abstract][Full Text] [Related]
19. HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC; Friedman SR
AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
[TBL] [Abstract][Full Text] [Related]
20. [HIV infection in intravenous drug dependent patients--Vienna 1988 results].
Loimer N; Presslich O; Hollerer E; Pfersmann V; Pakesch G; Pfersmann D
Wien Med Wochenschr; 1989 Jul; 139(14):334-6. PubMed ID: 2788964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
